Diabetic Ketoacidosis (DKA)

Diabetic ketoacidosis (DKA) is a potentially life-threatening complication of diabetes mellitus. Diabetic ketoacidosis arises because of a lack of insulin in the body. The lack of insulin and corresponding elevation of glucagon leads to increased release of glucose by the liver (a process that is normally suppressed by insulin) from glycogen via glycogenolysis and also through gluconeogenesis. Diabetic ketoacidosis occurs in 4.6–8.0 per 1000 people with diabetes annually.

    Related Conference of Diabetic Ketoacidosis (DKA)

    June 22-23, 2026

    16th World Congress on Endocrinology and Diabetes

    Paris, France
    July 20-21, 2026

    6th World Congress on Endocrine and Diabetes

    Paris, France
    August 17-18, 2026

    4th World congress and Expo on Diabetes

    Toronto, Canada
    August 20-21, 2026

    6th Annual Summit on Diabetes and Endocrinology

    Paris, France
    September 29-30, 2026

    22nd World Congress on Endocrinology & Diabetes

    Paris, France
    October 20-21, 2026

    32nd World Diabetes & Heart Congress

    Amsterdam, Netherlands
    March 29-30, 2027

    8th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands

    Diabetic Ketoacidosis (DKA) Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in